USE OF BETULINIC ACID FOR THE TREATMENT OR PREVENTION OF NONALCOHOLIC STEATOHEPATITIS AND NONALCOHOLIC FATTY LIVER DISEASE

摘要

Embodiments of the present disclosure pertain to methods of treating or preventing nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) in a subject by administering a therapeutic composition that includes betulinic acid to the subject. The betulinic acid in the therapeutic composition may be in crystalline or encased form. The subject to be treated may be a human being, such as a human being suffering from at least one of NASH or NAFLD. Additional embodiments of the present disclosure pertain to the aforementioned therapeutic compositions.